Kestra Medical Technologies (KMTS) Cash from Operations (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Cash from Operations data on file, last reported at 18720000.0 in Q2 2026.

• On a quarterly basis, Cash from Operations rose 22.18% year-over-year to 18720000.0 in Q2 2026; TTM through Apr 2026 was 81703000.0, a 5.28% decrease from a year earlier, with the FY2026 full-year figure at 81703000.0, down 5.28% from the prior year.
• Cash from Operations for Q2 2026 stood at 18720000.0, down from 18366000.0 in the prior quarter.
• Over the last five years, Cash from Operations for KMTS reached as high as 14948000.0 in Q2 2024 and fell as low as 26274000.0 in Q3 2025.
• Historically, Cash from Operations has averaged 19362111.11 across 3 years, with a median of 18343000.0 in 2025.
• Across the five-year window, Cash from Operations slumped 60.93% in 2025 and advanced 22.18% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 18056000.0 in 2024, then fell by 1.59% to 18343000.0 in 2025, then decreased by 2.06% to 18720000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 18720000.0 in Q2 2026, 18366000.0 in Q1 2026, and 18343000.0 in Q4 2025.